MicroRNA-506在胆管细胞中促进原发性胆汁性胆管炎样特征并促进免疫激活
本研究探讨了促炎细胞因子对胆管细胞中microRNA-506表达的调控及其在原发性胆汁性胆管炎(PBC)病理生理和免疫激活中的作用。白细胞介素-8(IL8)、IL12、IL17、IL18和肿瘤坏死因子α等促炎细胞因子可增强miR-506启动子活性;miR-506过表达诱导胆管细胞去分化、增殖和黏附受损、氧化应激和内质网应激、DNA损伤及 caspase-3依赖性凋亡,并与线粒体能量代谢受损和丙酮酸脱氢酶复合体E2过表达相关。miR-506过表达的胆管细胞与PBC免疫细胞共培养可诱导免疫细胞活化和增殖。
要点
- PBC肝脏中过表达的促炎细胞因子可增强胆管细胞miR-506启动子活性。
- miR-506过表达诱导胆管细胞去分化、增殖和黏附受损、氧化应激、DNA损伤及凋亡。
- miR-506过表达胆管细胞与PBC免疫细胞共培养可诱导免疫细胞活化和增殖。
核心结论
- 不同促炎细胞因子增强胆管上皮细胞中miR-506的表达;miR-506诱导胆管细胞PBC样特征并促进免疫激活,是PBC患者的潜在治疗靶点。
研究设计与样本
- 研究在人类胆管细胞中进行,采用荧光素酶报告基因实验检测miR-506启动子活性,采用质谱法分析细胞蛋白质组谱,并将miR-506过表达的胆管细胞与PBC免疫细胞共培养。
主要发现
- PBC肝脏中过表达的IL8、IL12、IL17、IL18和肿瘤坏死因子α等促炎细胞因子刺激人类胆管细胞中miR-506启动子活性。
- miR-506过表达在胆管细胞中诱导去分化,伴胆管和上皮标志物下调及间充质、促炎和促纤维化标志物上调。
- miR-506过表达损害胆管细胞增殖和黏附,增加氧化应激和内质网应激,导致DNA损伤,并使细胞对细胞毒性胆汁酸诱导的caspase-3依赖性凋亡敏感。
- 上述事件与线粒体能量代谢受损(质子漏和腺苷三磷酸生成减少)及丙酮酸脱氢酶复合体E2过表达相关。
- miR-506过表达的胆管细胞与PBC免疫细胞共培养诱导PBC免疫细胞活化和增殖。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease associated with autoimmune phenomena targeting intrahepatic bile duct cells (cholangiocytes). Although its etiopathogenesis remains obscure, development of antimitochondrial autoantibodies against pyruvate dehydrogenase complex E2 is a common feature. MicroRNA (miR) dysregulation occurs in liver and immune cells of PBC patients, but its functional relevance is largely unknown. We previously reported that miR-506 is overexpressed in PBC cholangiocytes and directly targets both Cl- / HCO3- anion exchanger 2 and type III inositol 1,4,5-trisphosphate receptor, leading to cholestasis. Here, the regulation of miR-506 gene expression and its role in cholangiocyte pathophysiology and immune activation was studied. Several proinflammatory cytokines overexpressed in PBC livers (such as interleukin-8 [IL8], IL12, IL17, IL18, and tumor necrosis factor alpha) stimulated miR-506 promoter activity in human cholangiocytes, as revealed by luciferase reporter assays. Experimental overexpression of miR-506 in cholangiocytes dysregulated the cell proteomic profile (by mass spectrometry), affecting proteins involved in different biological processes including mitochondrial metabolism. In cholangiocytes, miR-506 (1) induced dedifferentiation with down-regulation of biliary and epithelial markers together with up-regulation of mesenchymal, proinflammatory, and profibrotic markers; (2) impaired cell proliferation and adhesion; (3) increased oxidative and endoplasmic reticulum stress; (4) caused DNA damage; and (5) sensitized to caspase-3-dependent apoptosis induced by cytotoxic bile acids. These events were also associated with impaired energy metabolism in mitochondria (proton leak and less adenosine triphosphate production) and pyruvate dehydrogenase complex E2 overexpression. Coculture of miR-506 overexpressing cholangiocytes with PBC immunocytes induced activation and proliferation of PBC immunocytes. CONCLUSION: Different proinflammatory cytokines enhance the expression of miR-506 in biliary epithelial cells; miR-506 induces PBC-like features in cholangiocytes and promotes immune activation, representing a potential therapeutic target for PBC patients. (Hepatology 2018;67:1420-1440).
引用
- Erice O, Munoz-Garrido P, Vaquero J, et al. MicroRNA-506 promotes primary biliary cholangitis-like features in cholangiocytes and immune activation. Hepatology. 2018. PMID: 28922472. doi:10.1002/hep.29533
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。